» Articles » PMID: 20973823

Recent Epidemiology of Clostridium Difficile Infection During Hematopoietic Stem Cell Transplantation

Overview
Journal Clin Transplant
Specialty General Surgery
Date 2010 Oct 27
PMID 20973823
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

Given the limited information on Clostridium difficile infection (CDI) during hematopoietic stem cell transplantation (HSCT), we examined the recent epidemiology of CDI in HSCT recipients at our institution. During the two-yr retrospective study period (2005-2006), 361 transplants were performed: 60% allogeneic and 40% autologous. Among all hospitalized patients in a non-outbreak setting, CDI rates in HSCT recipients were ninefold higher than those in general patients and 1.4-fold higher than those in patients with cancer (24.0 vs. 2.6 vs. 16.8/10,000 patient-days respectively). Sixty-two episodes of CDI occurred in 51 (14%) HSCT recipients: 39 (18%) allogeneic vs. 12 (8%) autologous (p = 0.01). Almost half of CDI episodes occurred within 30 d post-HSCT and 22% before HSCT. Clostridium difficile toxin assay was initially positive in 28% of the first, 31% of the second and 27% of the third stool samples tested. All but one patient responded to therapy with metronidazole or vancomycin. Severe CDI occurred in one patient and recurrent CDI in two patients. CDI is common during HSCT especially in allogeneic transplants during the peri-HSCT period. Prospective studies to better define the epidemiology and identify unique risk factors for CDI and more accurate tests to confirm the diagnosis in this population are needed.

Citing Articles

Epidemiology and Outcomes of Recurrent Infection Among Hematopoietic Cell Transplant Recipients: A Single-center, Retrospective 10-year Study.

Sanchez E, Krantz E, Kassamali Escobar Z, Tverdek F, Rosen E, Ueda Oshima M Open Forum Infect Dis. 2024; 11(10):ofae570.

PMID: 39450393 PMC: 11500450. DOI: 10.1093/ofid/ofae570.


Fecal Microbiota Transplantation for -associated Diarrhea in Hematopoietic Stem Cell Transplant Recipients: A Single-center Experience from a Tertiary Center in India.

Prayag P, Patwardhan S, Ajapuje P, Melinkeri S, Gadhikar H, Palnitkar S Indian J Crit Care Med. 2024; 28(2):106-110.

PMID: 38323255 PMC: 10839937. DOI: 10.5005/jp-journals-10071-24607.


Diarrheal woes in transplantation from real world settings with special focus on clostridium difficile infection.

Yanamandra U, Khadwal A, Gupta S, Thomas T, Lad D, Taneja N Med J Armed Forces India. 2023; 79(6):679-683.

PMID: 37981921 PMC: 10654365. DOI: 10.1016/j.mjafi.2023.09.001.


Minimizing the risk of infection as an early complication of autologous stem cell transplantation.

Van Galen J, Maldonado S, Grose K, Bagley F, Olivier R, Van Hoose J Antimicrob Steward Healthc Epidemiol. 2023; 3(1):e158.

PMID: 37771742 PMC: 10523541. DOI: 10.1017/ash.2023.424.


The Role of Fecal Microbiota Transplantation in the Allogeneic Stem Cell Transplant Setting.

Metafuni E, Di Marino L, Giammarco S, Bellesi S, Limongiello M, Sora F Microorganisms. 2023; 11(9).

PMID: 37764025 PMC: 10536954. DOI: 10.3390/microorganisms11092182.


References
1.
Arango J, Restrepo A, Schneider D, Callander N, Ochoa-Bayona J, Restrepo M . Incidence of Clostridium difficile-associated diarrhea before and after autologous peripheral blood stem cell transplantation for lymphoma and multiple myeloma. Bone Marrow Transplant. 2006; 37(5):517-21. DOI: 10.1038/sj.bmt.1705269. View

2.
Jarvis W, Schlosser J, Jarvis A, Chinn R . National point prevalence of Clostridium difficile in US health care facility inpatients, 2008. Am J Infect Control. 2009; 37(4):263-70. DOI: 10.1016/j.ajic.2009.01.001. View

3.
Bilgrami S, Feingold J, Dorsky D, Edwards R, Bona R, Khan A . Incidence and outcome of Clostridium difficile infection following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant. 1999; 23(10):1039-42. DOI: 10.1038/sj.bmt.1701773. View

4.
Loo V, Poirier L, Miller M, Oughton M, Libman M, Michaud S . A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med. 2005; 353(23):2442-9. DOI: 10.1056/NEJMoa051639. View

5.
Avery R, Pohlman B, Adal K, Bolwell B, Goldman M, Kalaycio M . High prevalence of diarrhea but infrequency of documented Clostridium difficile in autologous peripheral blood progenitor cell transplant recipients. Bone Marrow Transplant. 2000; 25(1):67-9. DOI: 10.1038/sj.bmt.1702086. View